Thermo Fisher Scientific moved 1.2% this afternoon session, trading between a high of $492.05 and a low of $480.28 per share. Yesterday the stock finished at $482.85 per share, compared to an average analyst target price of $615.68.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The large-cap industrial machinery/components company is based in the United States, and over the last twelve months it has returned a dividend yield of 0.3%. Thermo Fisher Scientific has trailing twelve months earnings per share (EPS) of 14.63, which at today's prices amounts to a price to earnings (P/E) ratio of 33.4.
Based on its expected future earnings growth, the company has a price to earnings growth (PEG) ratio of 3.55. Usually a PEG ratio between 0 and 1 indicates a potentially undervalued company.
Overview of the Company's Gross Margins:
| Date Reported | Revenue ($ k) | Cost of Revenue ($ k) | Gross Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-23 | 44,915,000 | -25,944,000 | 42 | -16.0 |
| 2022-02-24 | 39,211,000 | -19,573,000 | 50 | 0.0 |
| 2021-02-25 | 32,218,000 | -16,214,000 | 50 | 13.64 |
| 2020-02-26 | 25,542,000 | -14,214,000 | 44 | -2.22 |
| 2019-02-27 | 24,358,000 | -13,501,000 | 45 | 0.0 |
| 2018-02-28 | 20,918,000 | -11,473,000 | 45 |
At 46.0%, Thermo Fisher Scientific's average gross margins are wider than the 34.2% average of its industry peer group, which suggests that the firm might have a competitive advantage.
